NEW ORLEANS – The Red Thread Promise has partnered with Tulane Hospital for Children and the Sickle Cell
Center of Southern Louisiana (SCCSL) at Tulane to provide free medical care for
a 4-year-old Haitian orphan. Christopher was diagnosed with sickle cell anemia
as an infant in his home country of Haiti, the poorest nation in the Western Hemisphere.
He is expected to arrive in New Orleans on March 9 to begin treatment at
Tulane.
Young Christopher has lived most of his life in an orphanage
in rural Haiti. His condition requires that he take daily medication and make frequent
trips for medical care, putting a great toll on the child. The devastation from
the 2010 earthquake in Haiti made it more difficult for Christopher to receive
the medical treatment he so desperately needs.
“We have been supporting Christopher’s medical care for the
majority of his short life, providing for his treatment while in the
orphanage,” states Sonya Yencer, Vice President of The Red Thread Promise. “Now
that he is in the States with his adoptive family, we are thrilled to continue
serving this child with the generous help and support of Tulane Hospital for
Children and SCCSL. We couldn’t ask for a better partnership.”
Christopher will soon travel to the New Orleans for a more
comprehensive evaluation and medical care at Tulane Hospital for Children and
the Sickle Cell Center of Southern Louisiana. Sickle cell anemia affects
millions throughout the world. It is an inherited disorder found more commonly
among people whose ancestors come from sub-Saharan Africa, South America, Cuba
or Central America. New Orleans has a large population of sickle cell patients
and some of the most advanced treatments are available at the Sickle Cell
Center of Southern Louisiana, which is good news for Christopher.
Sickle cell anemia causes red blood cells, which are usually
smooth and donut-shaped, to become stiff and assume a sickle shape. The sickled
red cells can have difficulty traveling through small vessels and begin to
stack up and cause blockages that deprive tissue and organs of oxygen-carrying
blood. These blockages bring about episodes of severe pain and can ultimately
damage tissue and vital organs. Currently, the only cure available for sickle
cell disease is a bone marrow transplant; however the disease can be managed
through proper medical treatment.
“While at Tulane, Christopher will undergo diagnostic
testing to determine the level of disease severity,” said Dr. Julie Kanter,
Assistant Professor of Pediatric Hematology-Oncology at Tulane, and the primary
physician who will oversee Christopher’s medical care. “This will include blood
tests, a cardiac exam and neurological testing. Tulane doctors will then
recommend a treatment regimen for Christopher based upon the results of his
medical tests.”
No comments:
Post a Comment